Neonatology
Novel Insights from Clinical Practice
Use of Skin Substitute Dressings in the Treatment of Staphylococcal Scalded Skin Syndrome in Neonates and Young InfantsBaartmans M.G.A.a · Dokter J.b · den Hollander J.C.c · Kroon A.A.d · Oranje A.P.eaDepartment of Paediatrics and bBurn Centre, Maasstadziekenhuis, cDepartment of Pathology, Erasmus MC, dDepartment of Paediatrics, Sub-Department of Neonatology, and eDepartment of Paediatric Dermatology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: April 07, 2010
Accepted: June 24, 2010
Published online: December 09, 2010
Issue release date: June 2011
Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 2
ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)
For additional information: https://www.karger.com/NEO
Abstract
Background: Staphylococcal scalded skin syndrome (SSSS) is a rare toxin-mediated skin disease caused by Staphylococcus aureus and seen in infants and children younger than 5 years. Objectives: The supportive role of skin substitutes in SSSS is stressed as a new and relatively unknown method. Methods: Retrospective observational case-series study, in neonates and young infants diagnosed with SSSS. Results: Seven infants with SSSS, treatment with antibiotics, skin substitutes, strict pain relief strategy and prognosis were described. One of them was severely affected and deceased. Conclusion: This study describes 7 infants with SSSS and stresses the important role of skin substitutes as Omiderm® and Suprathel® as valuable adjuvant treatment modality.
© 2010 S. Karger AG, Basel
Related Articles:
References
- Ladhani S: Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus. FEMS Immunol Med Microbiol 2003;39:181–189.
- Stanley JR, Amagai M: Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 2006;355:1800–1810.
- Blyth M, Estela C, Young AE: Severe staphylococcal scalded skin syndrome in children. Burns 2008;34:98–103.
- Patel GK, Finlay AY: Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol 2003;4:165–175.
- Patel GK: Treatment of staphylococcal scalded skin syndrome. Exp Rev Anti Infect Ther 2004;2:575–587.
-
Gait RC, Johnston GA: Acute skin conditions in children. Br J Hosp Med 2008;69:4.
- Johnston GA: Treatment of bullous impetigo and the staphylococcal scalded skin syndrome in Infants. Expert Rev Anti Infect Ther 2004;2:439–446.
- Ladhani S, Joannou CL, Lochrie DP, Evans RW, Poston SM: Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev 1999;12:224–242.
- Uhlig C, Rapp M, Hartmann B, Hierlemann H, Planck H, Dittel KK: Suprathel® – an innovative, resorbable skin substitute for the treatment of burn victims. Burns 2007;33:221–229.
- Benmier P: Omiderm® as an initial burn dressing. J Burn Care Rehabil 1994;15:461.
- Baartmans MG, Maas MH, Dokter J: Neonate with staphylococcal scalded skin syndrome. Arch Dis Child Fetal Neonatal Ed 2006;91:F25.
- Hoeger PH, Harper JI: Neonatal erythroderma: differential diagnosis and management of the ‘red baby’. Arch Dis Child 1998;79:186–191.
- De Groot R, Oranje AP, Vuzevski VD: Staphylococcal scalded skin syndrome. Ned Tijdschr Geneeskd 1984;128:1459–1463.
- Scully MC, Frieden IJ: Toxic epidermal necrolysis in early infancy. J Am Acad Dermatol 1992;27:340–344.
- Amagai M: Pemphigus as a paradigm of autoimmunity and cell adhesion. Keio J Med 2002;51:133–139.
- Oranje AP, Folkers E: The Tzanck smear: old, but still of inestimable value. Pediatr Dermatol 1988;5:127–129.
- Jursa-Kulesza J, Kordek A, Kopron K, Wojciuk B, Giedrys-Kalemba S: Molecular studies of an impetigo bullosa epidemic in full-term infants. Neonatology 2009;96:61–68.
- Barak M, Hershkowitz S, Rod R, Dror S: The use of a synthetic skin covering as a protective layer in the daily care of low birth weight infants. Eur J Pediatr 1989;148:665–666.
- Canter HI, Vargel I, Nasir S, Kayikcioglu A: Use of water-vapour permeable polyurethane film (Omiderm®) in the non-surgical treatment of aplasia cutis congenital. Scand J Plast Reconstr Surg Hand Surg 2004;38:232–235.
- Pfurtscheller K, Zobel G, Roedl S, Trop M: Use of Suprathel® dressings in a young infant with TEN. Pediatr Dermatol 2008;25:541–543.
- Mueller E, Haim M, Petnehazy T, Acham-Roschitz B, Trop M: An innovative local treatment for staphylococcal scalded skin syndrome. Eur J Clin Microbiol Infect Dis 2010;29:893–897.
- Greenwood JE, Dunn KW, Davenport PJ: Experience with severe extensive blistering skin disease in a paediatric burns unit. Burns 2000;26:82–87.
- Makhoul IR, Imad K, Hashman N, Sujov P: Staphylococcal scalded-skin syndrome in a very low birth weight premature infant. Pediatrics 2001;108:E16.
-
Orange JS, Hossny EM, Weiler CR, et al: Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006;117(suppl):S525–S553.
-
Warden GD, Chapter 9, Fluid resuscitation and early management: On: David N Herndon. Total Burn Care. 3e edition Saunders Elsevier 2006, pp 14–32.
Article / Publication Details
Received: April 07, 2010
Accepted: June 24, 2010
Published online: December 09, 2010
Issue release date: June 2011
Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 2
ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)
For additional information: https://www.karger.com/NEO
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
